This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Scott Preston Simonovich: Innovator in Cancer Treatment
Introduction
Scott Preston Simonovich is a notable inventor based in Walnut Creek, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. His innovative work has led to the creation of a patent that addresses critical medical needs.
Latest Patents
Scott holds a patent for "Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonists." This patent includes myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. The compounds and compositions provided in this patent may be utilized in the treatment of diseases or conditions, such as cancer.
Career Highlights
Scott is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen focuses on developing innovative solutions to combat serious health issues. His expertise in pharmacology and drug development has positioned him as a valuable asset in the field.
Collaborations
Scott collaborates with talented colleagues, including Gwenaella Rescourio and Ana Zurisadai Gonzalez Buenrostro. Together, they work on advancing research and development in the pharmaceutical sector.
Conclusion
Scott Preston Simonovich is a dedicated inventor whose work in cancer treatment exemplifies the impact of innovation in medicine. His contributions continue to pave the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile